Sarepta Therapeutics Balance Sheet (2010-2026) | SRPT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)	1,697.28M	1,599.11M	2,115.87M	1,233.88M	868.57M	1,038.62M	966.78M	871.67M	851.93M	541.93M	428.43M	427.29M	383.62M	197.85M	1,103.01M	240.87M	510.60M	404.56M	714.65M	496.29M
Short-term Investments (Quarter)	30.00M			779.50M	1,059.45M	1,033.86M	1,022.60M	1,010.43M	1,008.80M	1,191.61M	1,247.82M	963.50M	1,076.85M	1,000.53M	251.78M	281.89M	289.54M	237.92M	138.37M	188.74M
Cash & Current Investments (Quarter)	1,727.28M	1,599.11M	2,115.87M	2,013.38M	1,928.02M	2,072.48M	1,989.37M	1,882.10M	1,860.73M	1,733.54M	1,676.25M	1,390.79M	1,460.47M	1,198.39M	1,354.79M	522.76M	800.14M	642.47M	853.01M	685.03M
Receivables - Net (Quarter)	127.52M	149.32M	153.00M	178.20M	203.85M	201.50M	214.63M	223.84M	236.80M	318.86M	400.33M	378.80M	360.00M	434.52M	601.99M	659.40M	527.30M	395.70M	398.20M	394.80M
Receivables - Other (Quarter)	17.70M	29.10M	0.01M	17.70M	26.40M	21.90M	3.31M	62.00M	28.60M	35.40M	29.80M	30.10M	19.90M	66.40M	34.60M	55.20M	73.30M	128.70M	104.10M	136.40M
Receivables (Quarter)	145.22M	178.42M	153.01M	195.90M	230.25M	223.40M	217.94M	285.84M	265.40M	354.25M	430.13M	408.90M	379.90M	500.92M	636.59M	714.60M	600.60M	524.40M	502.30M	531.20M
Raw Materials (Quarter)	191.51M	40.16M	58.82M	41.27M	42.40M	250.39M	59.18M	84.47M	243.06M	114.62M	133.96M	150.01M	167.20M	208.32M	280.05M	298.98M	314.85M	325.54M	141.28M	136.96M
Work In Process (Quarter)							269.19M				318.46M		470.38M	482.17M	610.69M	762.23M	802.87M	885.42M	892.69M	981.04M
Finished Goods (Quarter)	29.47M	26.83M	26.72M	33.88M	35.50M	49.26M	38.15M	42.69M	47.61M	47.24M	61.81M	39.50M	52.90M	77.98M	47.21M	61.37M	70.98M	64.80M	65.32M	57.98M
Inventory (Quarter)	268.76M	288.47M	186.21M	199.00M	208.09M	221.19M	203.97M	202.68M	226.88M	244.01M	322.86M	373.53M	485.80M	565.92M	749.96M	941.43M	994.04M	1,077.17M	914.74M	1,001.11M
Prepaid Assets (Quarter)	141.67M	147.94M	149.03M	140.33M	3.28M	1.23M	149.89M	179.77M	3.14M	1.54M	3.35M	1.95M	3.93M	2.20M	90.46M	105.48M	4.11M	2.41M	4.00M	2.22M
Current Assets (Quarter)	2,265.22M	2,185.31M	2,604.10M	2,530.95M	2,469.30M	2,625.93M	2,557.86M	2,488.38M	2,472.61M	2,450.85M	2,579.33M	2,464.86M	2,683.64M	2,685.37M	3,073.46M	2,432.53M	2,656.99M	2,722.31M	2,537.94M	2,309.88M
Non-Current Assets
Construction in Progress (Quarter)
Property, Plant & Equipment (Net) (Quarter)	203.33M	199.25M	191.16M	187.25M	183.29M	181.00M	180.04M	182.86M	188.87M	212.37M	227.15M	249.30M	276.20M	305.79M	340.34M	360.59M	371.86M	358.94M	345.12M	336.24M
Long-Term Investments (Quarter)	39.97M	9.30M	9.90M	9.70M	33.23M	19.00M	31.32M	19.00M	19.00M	19.10M		7.46M	7.61M	181.77M	133.16M	154.37M	34.60M	1.04M	9.52M	81.94M
Intangibles (Quarter)	14.11M	14.20M	21.25M	13.33M	13.06M	13.06M	7.58M	7.20M	18.02M	19.50M	23.00M	28.93M	28.25M	27.57M	26.89M	26.20M	30.52M	29.68M	28.95M	31.38M
Goodwill & Intangibles (Quarter)	14.11M	14.20M	21.25M	13.33M	13.06M	13.06M	7.58M	7.20M	18.02M	19.50M	23.00M	28.93M	28.25M	27.57M	26.89M	26.20M	30.52M	29.68M	28.95M	31.38M
Long-Term Deferred Tax (Quarter)
Other Non-Current Assets (Quarter)	2.08M	3.47M	3.86M	3.73M	2.10M	293.12M	162.97M	8.57M	163.04M	2.22M	136.77M	15.58M	3.14M	15.58M	79.92M	15.58M	7.38M	4.17M	5.19M	151.96M
Non-Current Assets (Quarter)	493.86M	476.91M	543.88M	525.21M	527.55M	530.22M	570.50M	571.41M	653.28M	658.86M	685.25M	759.52M	740.62M	914.57M	889.71M	1,032.85M	1,022.83M	771.13M	811.76M	869.06M
Assets (Quarter)	2,759.07M	2,662.22M	3,147.97M	3,056.15M	2,996.85M	3,156.15M	3,128.37M	3,059.79M	3,125.89M	3,109.71M	3,264.58M	3,224.39M	3,424.26M	3,599.93M	3,963.17M	3,465.39M	3,679.81M	3,493.44M	3,349.70M	3,178.93M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	76.68M	44.16M	76.74M	54.01M	56.21M	118.46M	95.88M	106.71M	109.80M	87.95M	164.92M	91.54M	107.42M	118.77M	214.44M	156.10M	136.70M	94.02M	280.84M	70.38M
Notes Payables (Quarter)
Payables (Quarter)	76.68M	44.16M	76.74M	54.01M	56.21M	118.46M	95.88M	106.71M	109.80M	87.95M	164.92M	91.54M	107.42M	118.77M	214.44M	156.10M	136.70M	94.02M	280.84M	70.38M
Accumulated Expenses (Quarter)	240.14M	29.73M	48.30M	12.98M	1.09M	369.00M	65.95M	8.38M	2.63M	3.52M	78.73M	283.32M	50.02M	344.83M	91.12M	391.65M	55.23M	295.79M	359.66M	32.88M
Other Accumulated Expenses (Quarter)	18.96M	19.03M	15.05M	17.80M	16.42M	26.21M	5.31M	4.36M	9.79M	7.72M	6.47M	5.88M	4.99M	17.29M	13.47M	10.02M	5.93M	10.17M	6.96M	10.38M
Short term Debt (Quarter)											105.48M	105.59M	91.50M	91.59M				36.00M
Current Leases (Quarter)							15.49M				17.84M
Current Taxes (Quarter)			0.22M			4.09M	12.52M	16.09M	20.82M	24.68M	13.77M	18.29M			17.39M	79.86M	18.73M	9.09M	4.75M	13.79M
Current Deferred Revenue (Quarter)	89.24M	89.24M	89.24M	89.24M	89.24M	89.24M	89.24M	67.24M	44.99M	22.49M	50.42M	112.00M	122.04M	127.00M	130.26M	44.86M	395.43M	485.45M	443.40M	116.04M
Total Current Liabilities (Quarter)	425.02M	373.44M	452.73M	454.96M	545.57M	602.92M	619.60M	536.88M	498.65M	450.74M	653.66M	608.71M	688.49M	699.49M	731.68M	605.59M	919.95M	921.42M	1,095.29M	499.16M
Non-Current Liabilities
Non-Current Debt (Quarter)	1,092.98M	1,094.91M	1,096.88M	1,098.85M	1,100.87M	1,542.77M	1,544.29M	1,234.28M	1,235.52M	1,236.76M	1,132.52M	1,133.66M	1,134.81M	1,135.96M	1,137.12M	1,138.29M	1,139.46M	1,035.15M	828.97M	838.16M
Non-Current Deffered Revenue (Quarter)	619.23M	596.74M	574.24M	552.24M	529.99M	507.49M	485.00M	485.00M	485.00M	485.00M	437.00M	325.00M	325.00M	325.00M	325.00M	325.00M			83.91M	136.35M
Operating Leases (Quarter)	65.28M	63.43M	41.51M	38.62M	39.37M	35.23M	57.58M	53.93M	129.17M	134.75M	140.97M	140.10M	143.60M	170.01M	192.47M	205.46M	214.42M	215.04M	199.38M	198.50M
Other Non-Current Liabilities (Quarter)	50.80M	43.60M	43.60M	43.60M	43.60M	36.90M	36.90M	36.90M	36.10M	38.10M	38.10M	7.52M	48.20M	47.40M	47.40M	47.40M	47.40M	1.40M	1.53M	1.65M
Total Non-Current Liabilities (Quarter)	2,223.16M	2,149.09M	2,176.36M	2,155.67M	2,226.80M	2,688.41M	2,706.52M	2,310.14M	2,348.38M	2,307.25M	2,367.14M	2,255.67M	2,298.99M	2,331.46M	2,388.03M	2,275.26M	2,275.03M	2,171.91M	2,207.55M	1,672.18M
Total Liabilities (Quarter)	2,273.97M	2,192.69M	2,219.97M	2,199.27M	2,270.40M	2,725.31M	2,743.42M	2,347.04M	2,384.48M	2,345.35M	2,405.24M	2,263.19M	2,347.19M	2,378.86M	2,435.43M	2,322.66M	2,322.43M	2,173.32M	2,209.08M	1,673.83M
Shareholder's Equity
Total Debt (Quarter)	1,092.98M	1,094.91M	1,096.88M	1,098.85M	1,100.87M	1,542.77M	1,544.29M	1,234.28M	1,235.52M	1,236.76M	1,238.00M	1,239.25M	1,226.32M	1,227.56M	1,137.12M	1,138.29M	1,139.46M	1,071.15M	828.97M	838.16M
Common Equity (Quarter)	485.11M	469.53M	928.01M	856.89M	726.46M	430.84M	384.95M	712.75M	741.41M	764.36M	859.34M	961.19M	1,077.07M	1,221.07M	1,527.74M	1,142.72M	1,357.38M	1,320.12M	1,140.62M	1,505.10M
Shareholder's Equity (Quarter)	485.11M	469.53M	928.01M	856.89M	726.46M	430.84M	384.95M	712.75M	741.41M	764.36M	859.34M	961.19M	1,077.07M	1,221.07M	1,527.74M	1,142.72M	1,357.38M	1,320.12M	1,140.62M	1,505.10M
Liabilities and Shareholders Equity (Quarter)	2,759.07M	2,662.22M	3,147.97M	3,056.15M	2,996.85M	3,156.15M	3,128.37M	3,059.79M	3,125.89M	3,109.71M	3,264.58M	3,224.39M	3,424.26M	3,599.93M	3,963.17M	3,465.39M	3,679.81M	3,493.44M	3,349.70M	3,178.93M
Treasury Shares (Quarter)			1.32M				1.83M				2.24M				2.15M		-0.65M	0.65M	0.65M	0.66M
Retained Earnings (Quarter)	0.00M	-3084.77M	-0.02M	-0.31M	-3543.25M	-3.21M	-3910.24M	-0.42M	-4450.93M	-0.64M	0.92M	-4410.09M	-1.03M	-4370.02M	-0.22M	0.03M	-4461.59M	0.22M	0.27M	-0.12M

Research Tools

Developers

Sarepta Therapeutics Balance Sheet (2010-2026) | SRPT

Research Tools

Developers

Sarepta Therapeutics Balance Sheet (2010-2026) | SRPT

Create an account

Sign In

Reset Password